- Series B
- €23.2M
WhiteLab Genomics is a Paris company whose AI platform, ALFRED, designs delivery vehicles for genomic medicines, including AAV capsids and lipid nanoparticles, along with genetic payloads. With the Paris Brain Institute, its engineered AAVs crossed the blood-brain barrier in vivo with no detectable liver signal. In October 2026 it closed a €23.2 million Series B led by AVP to extend validation to non-viral delivery and grow its Boston hub.